UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

Annals of oncology, 2016-03, Vol.27 (3), p.379-390

2016

Volltextzugriff (PDF)

Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis

Annals of oncology, 2013-01, Vol.24 (1), p.101-108

2013

Volltextzugriff (PDF)

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients

Annals of oncology, 2013-12, Vol.24 (12), p.2990-2994

2013

Volltextzugriff (PDF)

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

Journal for immunotherapy of cancer, 2019-08, Vol.7 (1), p.205-13, Article 205

2019

Volltextzugriff (PDF)

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

European journal of cancer (1990), 2018-09, Vol.101, p.191-200

2018

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3068-3077

2000

Volltextzugriff (PDF)

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

Annals of oncology, 2021-02, Vol.32 (2), p.208-217

2021

Volltextzugriff (PDF)

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer

British journal of cancer, 2011-03, Vol.104 (7), p.1079-1084

2011

Volltextzugriff (PDF)

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer

Annals of oncology, 2009-03, Vol.20 (3), p.469-474

2009

Volltextzugriff (PDF)

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

The pharmacogenomics journal, 2016-10, Vol.16 (5), p.472-477

2016

Volltextzugriff (PDF)

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

British journal of cancer, 2010-09, Vol.103 (7), p.1019-1024

2010

Volltextzugriff (PDF)

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

British journal of cancer, 2009-07, Vol.101 (2), p.232-237

2009

Volltextzugriff (PDF)

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Annals of oncology, 2019-06, Vol.30 (6), p.921-926

2019

Volltextzugriff (PDF)

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG

Annals of oncology, 2006-02, Vol.17 (2), p.262-269

2006

Volltextzugriff (PDF)

Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the 'Mario Negri' Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

British journal of cancer, 2004-06, Vol.90 (11), p.2112-2117

2004

Volltextzugriff (PDF)

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

British journal of cancer, 2005-07, Vol.93 (1), p.35-40

2005

Volltextzugriff (PDF)

Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients

Annals of oncology, 2001-09, Vol.12 (9), p.1301-1306

2001

Volltextzugriff (PDF)

Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review

Cancer treatment reviews, 2023-03, Vol.114, p.102511-102511, Article 102511

2023

Volltextzugriff (PDF)

Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials

ESMO open, 2022-04, Vol.7 (2), p.100433, Article 100433

2022

Volltextzugriff (PDF)

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

British journal of cancer, 2006-04, Vol.94 (7), p.1016-1020

2006

Volltextzugriff (PDF)

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer

Annals of oncology, 2003-02, Vol.14 (2), p.227-232

2003

Volltextzugriff (PDF)

Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

Annals of oncology, 2000-09, Vol.11 (9), p.1127-1130

2000

Volltextzugriff (PDF)

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3112-3120

1996

Volltextzugriff (PDF)

Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?

Cancer treatment reviews, 2017-11, Vol.60, p.100-108

2017

Volltextzugriff (PDF)

Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization

Radiology, 1995-12, Vol.197 (3), p.812-818

1995

Volltextzugriff (PDF)

1 – 25 von 889

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(786)
Mit Volltextzugriff
(612)

Publikationsform

Artikel
(888)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(685)
Life Sciences & Biomedicine
(682)
Female
(616)
Middle Aged
(450)
Male
(425)
Adult
(402)
Aged
(352)
Biological And Medical Sciences
(318)
Medical Sciences
(299)
Oncology
(233)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(138)
Pharmacology. Drug Treatments
(121)
Treatment Outcome
(114)
Adolescent
(105)
Breast Neoplasms - Drug Therapy
(93)
Prognosis
(85)
Chemotherapy
(84)
Urology & Nephrology
(82)
Antineoplastic Agents
(80)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients

Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review

Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer

Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer

Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?

Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization

Aktive Filter

Suchergebnisse filtern